HSP90AA1 and neoplasm: When comparing matched pairs of a primary tumor and a brain metastasis, 13/30 (43%) brain metastases had increased HSP90 levels compared to the primary tumor, from which 10/13 (77%) switched from HSP90low (score ≤ 1) to HSP90high (score ≥ 2).